Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Docpharma Assessoria e Consultoria is a pharmaceutical regulatory and medical compliance consulting firm based in Cotia, São Paulo, Brazil. Based on the page content, it is not a typical SaaS or enterprise software vendor. Instead, it provides professional services around regulatory licensing, document compliance, operational process setup, and follow-up on regulatory procedures. Its services are aimed at companies that need to work with regulatory authorities, with ANVISA specifically mentioned in the body text.
The main service modules disclosed on the page are “Assessoria” and “Consultoria.” The former focuses on helping client companies complete license applications with regulatory authorities, supporting document remediation, and embedding good-practice requirements into daily operations. The latter emphasizes first diagnosing the current situation, then proposing solutions, as well as preparing and following up on submissions to regulatory authorities. Overall, this is more of a project-based consulting delivery model than an online system, workflow engine, or document management platform.
The captured content does not disclose packages, quotes, billing methods, contract terms, a free plan, or trial information. The page provides a phone number, WhatsApp, email, and physical address, and mentions that visits can be scheduled. This suggests the service is more likely priced by project, consulting scope, or custom quotation, but specific pricing cannot be confirmed from the available text.
From a SaaS perspective, the page does not present information on third-party integrations, team collaboration and permissions, data security and compliance, cloud deployment or self-hosting, APIs, or developer support. It also has no login portal, product screenshots, or system module descriptions. Therefore, it should not be directly evaluated as a purchasable software platform. If a company needs compliance consulting, application document preparation, and guidance through ANVISA procedures, Docpharma’s positioning is a reasonable fit. If the requirement is configurable workflows, electronic signatures, audit trails, document version control, or similar system capabilities, these should be confirmed separately, or a QMS/compliance management software product should be considered instead.
Its strengths are a clear industry focus, concentration on pharmaceutical regulatory scenarios, and coverage of licensing, documentation, operational processes, and application follow-up. Its weaknesses are limited public information: it does not disclose client cases, service boundaries, delivery timelines, or pricing, and it provides no description of any SaaS capabilities. It is suitable for local Brazilian pharmaceutical, regulatory affairs, and regulated companies seeking compliance consulting support. It is not suitable for completing enterprise software selection based on the website alone.
Access from mainland China cannot be determined from the text, and payment methods are not disclosed. Chinese companies conducting pharmaceutical-related business in Brazil could consider it as a lead for local compliance advisory support. If the need is within mainland China, alternatives may include domestic drug registration consultants, GMP/GSP compliance consulting firms, or pharmaceutical QMS, document management, and compliance workflow management software.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on docpharma.com.br official site.
docpharma.com.br is an Brazil SaaS provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach docpharma.com.br directly.